Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate CancerMatti Annala, Kim N., Alexander W. Wyatt et al.|Cancer Discovery|2018Cited by 520
Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway InhibitionMatti Annala, Alexander W. Wyatt, Sinja Taavitsainen et al.|Clinical Cancer Research|2021Cited by 94
Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate CancerCameron Herberts, Alexander W. Wyatt, Andrew J. Murtha et al.|European Urology|2020Cited by 90
Identification of Hypermutation and Defective Mismatch Repair in ctDNA from Metastatic Prostate CancerElie Ritch, Alexander W. Wyatt, Simon Fu et al.|Clinical Cancer Research|2019Cited by 77
Abstract PR09: Frequency and etiology of ctDNA-positive metastatic prostate cancer with BRCA2, ATM, or CDK12 mutationsEvan W. Warner, Alexander W. Wyatt, Steven Yip et al.|Clinical Cancer Research|2020Cited by 1